DrugCite
Search

BELOC ZOK

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Beloc Zok Adverse Events Reported to the FDA Over Time

How are Beloc Zok adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Beloc Zok, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Beloc Zok is flagged as the suspect drug causing the adverse event.

Most Common Beloc Zok Adverse Events Reported to the FDA

What are the most common Beloc Zok adverse events reported to the FDA?

Drug Interaction
64 (6.22%)
Bradycardia
26 (2.53%)
Stevens-johnson Syndrome
20 (1.94%)
Hypotension
18 (1.75%)
Atrial Fibrillation
15 (1.46%)
Syncope
15 (1.46%)
Diarrhoea
14 (1.36%)
Renal Failure Acute
14 (1.36%)
Toxic Epidermal Necrolysis
11 (1.07%)
Hypoglycaemia
10 (.97%)
Cardiac Failure
9 (.87%)
Show More Show More
Pruritus
9 (.87%)
Condition Aggravated
8 (.78%)
Drug Exposure During Pregnancy
8 (.78%)
Fall
8 (.78%)
Arrhythmia
7 (.68%)
Ascites
7 (.68%)
Asthenia
7 (.68%)
Cholestasis
7 (.68%)
Depression
7 (.68%)
Hyperkalaemia
7 (.68%)
Hypertension
7 (.68%)
Liver Disorder
7 (.68%)
Metabolic Acidosis
7 (.68%)
Nausea
7 (.68%)
Oedema Peripheral
7 (.68%)
Sinus Bradycardia
7 (.68%)
Abdominal Pain
6 (.58%)
Blister
6 (.58%)
Blood Pressure Increased
6 (.58%)
Coma
6 (.58%)
Dizziness
6 (.58%)
Hepatic Cirrhosis
6 (.58%)
Incorrect Dose Administered
6 (.58%)
Lip Erosion
6 (.58%)
Overdose
6 (.58%)
Shock Hypoglycaemic
6 (.58%)
Somnolence
6 (.58%)
Tachycardia
6 (.58%)
Throat Tightness
6 (.58%)
White Blood Cell Count Increased
6 (.58%)
Aspartate Aminotransferase Increase...
5 (.49%)
Blood Creatinine Increased
5 (.49%)
Blood Pressure Decreased
5 (.49%)
Blood Pressure Fluctuation
5 (.49%)
Bradyarrhythmia
5 (.49%)
Drug Ineffective
5 (.49%)
Dyspnoea Exertional
5 (.49%)
Gamma-glutamyltransferase Increased
5 (.49%)
General Physical Health Deteriorati...
5 (.49%)
Hepatitis Toxic
5 (.49%)
Hypersensitivity
5 (.49%)
Ocular Hyperaemia
5 (.49%)
Pain In Extremity
5 (.49%)
Pancytopenia
5 (.49%)
Peripheral Arterial Occlusive Disea...
5 (.49%)
Restlessness
5 (.49%)
Rhabdomyolysis
5 (.49%)
Urine Colour Abnormal
5 (.49%)
Agitation
4 (.39%)
Burning Sensation Mucosal
4 (.39%)
Cardioactive Drug Level Increased
4 (.39%)
Cardiovascular Insufficiency
4 (.39%)
Catheterisation Cardiac
4 (.39%)
Conjunctivitis
4 (.39%)
Dehydration
4 (.39%)
Dyspnoea
4 (.39%)
Eye Pruritus
4 (.39%)
Fatigue
4 (.39%)
Feeling Cold
4 (.39%)
Haemoglobin Decreased
4 (.39%)
Humerus Fracture
4 (.39%)
Hypercholesterolaemia
4 (.39%)
Loss Of Consciousness
4 (.39%)
Peripheral Vascular Disorder
4 (.39%)
Pneumonia
4 (.39%)
Prothrombin Time Abnormal
4 (.39%)
Pyrexia
4 (.39%)
Rash
4 (.39%)
Reflux Oesophagitis
4 (.39%)
Renal Failure Chronic
4 (.39%)
Rhinorrhoea
4 (.39%)
Stupor
4 (.39%)
Swollen Tongue
4 (.39%)
Ventricular Extrasystoles
4 (.39%)
Vomiting
4 (.39%)
Activated Partial Thromboplastin Ti...
3 (.29%)
Angina Pectoris
3 (.29%)
Anticholinergic Syndrome
3 (.29%)
Anxiety
3 (.29%)
Atrial Septal Defect
3 (.29%)
Atrioventricular Block Complete
3 (.29%)
C-reactive Protein Increased
3 (.29%)
Cardiogenic Shock
3 (.29%)
Chills
3 (.29%)
Confusional State
3 (.29%)
Drug Level Increased
3 (.29%)
Electrolyte Imbalance
3 (.29%)
Gait Disturbance
3 (.29%)
Hepatocellular Injury
3 (.29%)
Hyperkeratosis
3 (.29%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Beloc Zok, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Beloc Zok is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Beloc Zok

What are the most common Beloc Zok adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Beloc Zok, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Beloc Zok is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Beloc Zok According to Those Reporting Adverse Events

Why are people taking Beloc Zok, according to those reporting adverse events to the FDA?

Hypertension
243
Drug Use For Unknown Indication
56
Essential Hypertension
17
Atrial Fibrillation
15
Cardiac Failure
13
Product Used For Unknown Indication
12
Show More Show More
Acute Myocardial Infarction
11
Myocardial Ischaemia
7
Cardiovascular Disorder
7
Coronary Artery Disease
6
Tachyarrhythmia
6
Renal Hypertension
4
Cardiac Disorder
4
Atrial Flutter
4
Supraventricular Tachycardia
3
Cardiac Failure Congestive
3
Coronary Artery Aneurysm
2
Myocardial Infarction
2
Tachycardia
2
Secondary Hypertension
2
Acute Coronary Syndrome
2
Ill-defined Disorder
2
Arrhythmia
2
Anxiety
1
Hypertonia
1
Ventricular Tachycardia
1
Palpitations
1
Congestive Cardiomyopathy
1
Hypertensive Cardiomyopathy
1

Beloc Zok Case Reports

What Beloc Zok safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Beloc Zok. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Beloc Zok.